The company is a medical devices company that has developed a break-through technological platform for the treatment of heart failure. Congestive heart failure is a gradually progressive condition where the heart muscle weakens leading to a decrease in contraction force and inadequate delivery of oxygen-rich blood to the body. Using the recent discovery that aberrant cardiac motion causes congestive heart failure by causing abnormal growth and remodeling of the heart, the company has developed a minimally invasive direct cardiac compression device that restores normal cardiac motion to the heart by application of gentle pressure. The restoration of normal cardiac motion enables to the heart to remodel back to normal healthy state. This technology is poised to replace or work in conjunction with already existing treatments including invasive surgery, pharmaceuticals, and electrical and stem cell therapies.